Continuation of pediatric expansion in adolescents of PREVENT-19 Phase 3 trial will evaluate safety and immunogenicity of a booster dose
Sputnik M is a new member of the Sputnik vaccines family
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
By cutting pain crises & boosting haemoglobin
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Medical experts point to a growing body of research linking energy drinks to liver injury
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
Panacea Biotec receives LoA from CMSS
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
Subscribe To Our Newsletter & Stay Updated
